Giving Everyone a Shot #118

Deepnews Logo

Deepnews Digest #118

Giving Everyone a Shot

Editor: Christopher Brennan
As vaccine rollouts start to suppress the coronavirus in some countries, others are wondering when it will be their turn. With any global topic, such as patents, there is a lot to take in. Deepnews can be particularly useful in these sorts of media monitoring situations, as by focusing on quality it finds articles that are contributing to the conversation with reporting and analysis, rather than putting forward the same content as everyone else. Here is a selection on the subject of vaccines and vaccine patents.

SIGN UP TO GET THE DIGEST

Seeing this and not signed up?
Deepnews’s main business is providing our technology for those who want to be able to differentiate between high and low-quality articles, but we also like to share some of the gems our model highlights with you. Sign up above to get our weekly Digest as well as mid-week blog posts.
Published every Friday

Washington Post

Europe’s vaccine campaign is accelerating. It expects to match the U.S. by July.

ROME — After months of supply shortages and embarrassing blunders, Europe’s coronavirus vaccine campaign is at last sprinting ahead, renewing hopes that the continent might meet its initial inoculation goals and tame the virus even while relaxing restrictions.

Read more


Score: stars image Confidence: 69%

Find out more

Deustche Welle

Germany, Russia and the Sputnik V vaccine — a tale of soft power

Early on in the pandemic Germany committed to purchasing all vaccines through the EU despite delays. Now some want to make an exception for the Russian vaccine Sputnik V.

Read more


Score: stars image Confidence: 99%

Find out more

MinnPost

For mRNA vaccines, COVID-19 might just be the beginning

The success of the Moderna and Pfizer shots has researchers thinking about a better flu vaccine — and maybe a treatment for cancer.

Read more


Score: stars image Confidence: 99%

Find out more

MIT Tech Review

Why mixing vaccines could help boost immunity

New trials on mixing different types of vaccines are underway. Could vaccine combinations help stop variants from bypassing our immune systems?

Read more

Editor’s Note:

With vaccines being recommended and unrecommended for different groups, mixing of vaccines has become an issue. Here Cassandra Willyard reports. – Christopher Brennan, Editor


Score: stars image Confidence: 99%

Find out more

Times of Israel

Pfizer vaccine 96.7% effective at preventing COVID deaths, Israeli data shows

Shots also 97.5% effective against serious illness, and 95.3% effective in preventing infection, according to study published in prestigious medical journal

Read more


Score: stars image Confidence: 99%

Find out more

The Conversation

COVID vaccines: why waiving patents won’t fix global shortage – scientist explains

COVID-19 vaccines are key to ending the pandemic. From a humanitarian, moral and pragmatic perspective, the countries must unite to ensure fair and rapid access to these vaccines, worldwide. As political and health leaders have stressed: no one is safe until we are all safe.

Read more


Score: stars image Confidence: 99%

Find out more

Forbes

It’s Time For Big Pharma To Waive Their Patents On COVID-19 Vaccines

At a time when societies are being ravaged by a pandemic that knows no boundaries and is mutating more dangerously over time, COVID-19 vaccine manufacturers are being given a chance to support the Biden administration and developing countries by waiving their patents. There has never been a more clear opportunity for public and private organizations to solve a problem together.

Read more


Score: stars image Confidence: 99%

Find out more

Project Syndicate

Will Corporate Greed Prolong the Pandemic?

The shortfall in global COVID-19 vaccine production could be closed if manufacturers around the world were granted access to the necessary technology and knowledge. But first, the US and other key governments must recognize the drug companies’ opposition to this solution for the deadly rent-seeking that it is.

Read more


Score: stars image Confidence: 99%

Find out more

Marginal Revolution

Patents are Not the Problem!

For the last year and a half I have been shouting from the rooftops, “invest in capacity, build more factories, shore up the supply lines, spend billions to save trillions.” Fortunately, some boffins in the Biden administration have found a better way, “the US supports the waiver of IP protections on COVID-19 vaccines to help end the pandemic.” Waive IP protections. So simple. Why didn’t I think of that???

Read more


Score: stars image Confidence: 99%

Find out more

Business Standard

Access to foreign Covid-19 vaccine a long haul, say Indian companies

US pharmaceutical associations feel that the decision to support the patent waiver would weaken already-strained supply chains

Read more

Editor’s Note:

The surge of COVID in India has drawn global concern. Here Business Standard reports from Mumbai about the timeline for getting much needed vaccines. – Christopher Brennan, Editor


Score: stars image Confidence: 99%

Find out more

Johns Hopkins University

Organ transplant recipients remain vulnerable to COVID-19 even after second vaccine dose

Johns Hopkins Medicine researchers urge people who are immunocompromised to strictly follow COVID-19 safety measures, even after vaccination

Read more


Score: stars image Confidence: 99%

Find out more

POLITICO

What’s wrong with Biden’s promise to waive vaccine patents

The US’s move on intellectual property is in the right direction, but where will it go from here?

Read more


Score: stars image Confidence: 99%

Find out more

Teen Vogue

Vaccine Nationalism: What Is It and How Is It Playing Out During COVID-19?

In many parts of the United States, the newly vaccinated are making summer vacation plans and reuniting with loved ones. According to the most recent data, 32.1% of Americans are fully vaccinated and 45% have received at least one dose. But a very different story is playing out elsewhere in the world, where COVID-19 variants are raging and dozens of countries are still reporting vaccination rates in the single digits.

Read more


Score: stars image Confidence: 99%

Find out more

WSJ ($)

Covid-19 Retreats in the West, but the Pandemic Fight Is Far From Over

With parts of Asia and Latin America under siege, global deaths in 2021 on track to exceed the 2020 toll

Read more


Score: stars image Confidence: 99%

Find out more

Euronews

What is the argument against lifting COVID vaccine patents?

The world’s major vaccine-producing countries are for the first time opening the door to the suspension of intellectual property rights for COVID-19 vaccines.

Read more


Score: stars image Confidence: 99%

Find out more

Boston Globe

Moderna’s CEO says he “didn’t lose a minute of sleep” over potential waiver of vaccine patents

Moderna chief executive Stephane Bancel on Thursday shrugged off the Biden administration’s support for suspending patents for coronavirus vaccines, saying drug firms in other countries would struggle to mass-produce a rival to the blockbuster vaccine that has made his company a household name.

Read more

Editor’s Note:

Pharma companies have been watching what is happening at the WTO closely. Here the Globe reports on the reaction of the Boston-based Moderna. – Christopher Brennan, Editor


Score: stars image Confidence: 98%

Find out more

SF Chronicle

Even in S.F. Bay Area, many people refuse to get shots. We asked them why

A 69-year-old UC Berkeley public health graduate who voted for Bernie Sanders. A 28-year-old Fremont digital designer and COVID-19 survivor. An immigrant from India, 26, who fixes phones in a Fairfield mall.

Read more


Score: stars image Confidence: 98%

Find out more

The Africa Report

Egypt: Local vaccine production can save tourism

With only less than 1% of its population vaccinated against Covid-19, Egypt is quickly entering its third wave with new restrictions being rolled out. But relying on local vaccine production rather than the beleaguered COVAX initiatives could be its remedy.

Read more


Score: stars image Confidence: 98%

Find out more

STAT News

The U.S. opened pandora’s box on IP waivers for Covid-19 vaccines. What happens now?

In a surprising move, the Biden administration has said it will support a controversial proposal to temporarily waive intellectual property rights for Covid-19 vaccines in a bid to increase global supplies of desperately needed doses. The proposal, which was introduced before the World Trade Organization last fall by South Africa and India, would cover patents, industrial designs, copyrights, and protection of trade secrets. Ultimately, a waiver would make it easier for countries that permit compulsory licensing to allow a manufacturer to export vaccines.

Read more


Score: stars image Confidence: 97%

Find out more

Nikkei Asian Review

Biden’s vaccine patent waiver just start of global supply challenge

WASHINGTON/VIENNA/TOKYO — President Joe Biden’s decision to back a waiver on patent protections for COVID-19 vaccines lowers one hurdle to broader production, but the specialized skills required in quality control and manufacturing look likely to create another bottleneck.

Read more


Score: stars image Confidence: 95%

Find out more

Unsubscribe

Archives

%SENDER-INFO-SINGLELINE%